Image For Activity Cover
CSFP2305 - CME - Nephrocalcinosis and End-Stage Renal Disease Resulting from Amyloidosis Secondary to Injection Drug Use
Course Description

Faculty/Authors
Michael Brown, DO
Department Of Laboratory Medicine and Pathology
University Of Washington School of Medicine
 
Nicole Yarid, MD
King County Medical Examiner's Office
 
Seattle, Washington

CME Credit: 2.0
Estimated Completion Time: 2 hours
Format: Online Educational Activity and Post Exam

Physician Competencies: Patient Care, Medical Knowledge

Eligibility for CME credit: Max three attempts. You will have a maximum of three attempts to meet the following criteria:

  • Module ≥80% = CME credit
  • Module <80% = No CME credit, after a maximum of three attempts

Default Credit Type: None (You must meet the eligibility requirements in order to obtain CME credit.)

Accreditation Statement:
The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education (CME) for physicians. This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME).

Credit Designation Statement: The American Society for Clinical Pathology (ASCP) designates this enduring material for a maximum of 2 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Instructions

  1. Review the Technical Considerations.
  2. Click Go to Course to view an overview of the modules in this course.
  3. Click Access to begin the course.
  4. Choose the CME Activity to earn CME credit.

To claim CME credit for the exercise, do the following:

  1. Review the Educational Activity.
  2. Complete and submit the Post Exam. You will have a maximum of three attempts to obtain the required score. You will be notified if you have met the credit requirements after each attempt.
  3. Submit the course Evaluation.
  4. Enter the maximum number of credits offered.

Faculty Disclosures

Technical Considerations

Release Date: 10/31/2023
Review Date:
Expiration Date: 12/31/2025

Learning Objectives
Upon completion of this activity, you will be able to:
  • discuss the most common causes of secondary amyloidosis;

  • describe the histologic findings diagnostic of renal amyloidosis and special features associated with rapid progression to end-stage renal disease;

  • distinguish between ancillary testing modalities used to diagnose and subtype amyloidosis;

  • identify the top differential diagnoses associated with renal amyloidosis; and

  • recognize the clinical features of nephrocalcinosis.

Summary
Availability: On-Demand
Credit Offered:
2 CME Credits
Powered By